1. Home
  2. SNGX vs SGMA Comparison

SNGX vs SGMA Comparison

Compare SNGX & SGMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • SGMA
  • Stock Information
  • Founded
  • SNGX 1987
  • SGMA 1993
  • Country
  • SNGX United States
  • SGMA United States
  • Employees
  • SNGX N/A
  • SGMA N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • SGMA Electrical Products
  • Sector
  • SNGX Health Care
  • SGMA Technology
  • Exchange
  • SNGX Nasdaq
  • SGMA Nasdaq
  • Market Cap
  • SNGX 6.5M
  • SGMA 6.2M
  • IPO Year
  • SNGX 1987
  • SGMA 1994
  • Fundamental
  • Price
  • SNGX $2.16
  • SGMA $1.25
  • Analyst Decision
  • SNGX
  • SGMA
  • Analyst Count
  • SNGX 0
  • SGMA 0
  • Target Price
  • SNGX N/A
  • SGMA N/A
  • AVG Volume (30 Days)
  • SNGX 199.2K
  • SGMA 34.0K
  • Earning Date
  • SNGX 05-09-2025
  • SGMA 03-14-2025
  • Dividend Yield
  • SNGX N/A
  • SGMA N/A
  • EPS Growth
  • SNGX N/A
  • SGMA N/A
  • EPS
  • SNGX N/A
  • SGMA N/A
  • Revenue
  • SNGX $119,371.00
  • SGMA $311,706,094.00
  • Revenue This Year
  • SNGX N/A
  • SGMA N/A
  • Revenue Next Year
  • SNGX N/A
  • SGMA N/A
  • P/E Ratio
  • SNGX N/A
  • SGMA N/A
  • Revenue Growth
  • SNGX N/A
  • SGMA N/A
  • 52 Week Low
  • SNGX $1.68
  • SGMA $0.96
  • 52 Week High
  • SNGX $14.83
  • SGMA $6.47
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 51.88
  • SGMA 55.77
  • Support Level
  • SNGX $1.97
  • SGMA $0.96
  • Resistance Level
  • SNGX $2.23
  • SGMA $1.22
  • Average True Range (ATR)
  • SNGX 0.17
  • SGMA 0.10
  • MACD
  • SNGX 0.02
  • SGMA 0.01
  • Stochastic Oscillator
  • SNGX 86.36
  • SGMA 78.38

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About SGMA SigmaTron International Inc.

Sigmatron International Inc is an independent provider of electronic manufacturing services (EMS). It provides manufacturing and assembly services ranging from the assembly of individual components to the assembly and testing of box-build electronic products. The company manufactures products like printed circuit board assemblies, electro-mechanical subassemblies, and completely assembled (box-build) electronic products which are incorporated into finished products and sold in various industries, particularly industrial electronics, consumer electronics, and life sciences. In some instances, it manufactures and assembles the completed finished product for its customers. Geographically, the company derives maximum revenue from Mexico and the rest from the United States, China, and Vietnam.

Share on Social Networks: